MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INKT MiNK Therapeutics, Inc.

交易中 03-02 10:06:02 EST

10.98

+0.03

+0.30%

最高10.98	最低10.72	成交量1,379
今开10.72	昨收10.95	日振幅2.40%
总市值5,155万	流通市值1,871万	总股本469.42万
成交额1.49万	换手率0.08%	流通股本170.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":10.9826,"timestamp":1772463939942,"preClose":10.95,"halted":0,"volume":1379,"delay":0,"changeRate":0.0029771689497717266,"floatShares":1703200,"shares":4694155,"eps":-3.021903,"marketStatus":"交易中","change":0.0326,"latestTime":"03-02 10:06:02 EST","open":10.72,"high":10.9826,"low":10.72,"amount":14892.5663495,"amplitude":0.023982,"askPrice":11.22,"askSize":9,"bidPrice":10.75,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-3.021903,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":10.95,"postHourTrading":{"tag":"盘后","latestPrice":10.95,"preClose":10.95,"latestTime":"19:56 EST","volume":130,"amount":1405.6375,"timestamp":1772240192264,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.11424},"requestUrl":"/m/hq/s/INKT","defaultTab":"news","newsList":[{"id":"1155030328","title":"MiNK Therapeutics与威斯康星大学麦迪逊分校联合启动同种异体iNKT细胞疗法（Agent-797）一期临床试验，评估移植物抗宿主病预防效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1155030328","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155030328?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:04","pubTimestamp":1767891873,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics与威斯康星大学麦迪逊分校共同宣布，正式启动针对同种异体iNKT细胞疗法（代号Agent-797）的一期临床试验。该试验旨在评估该疗法在预防移植物抗宿主病方面的潜在疗效与安全性。\n这项合作将结合MiNK Therapeutics在细胞治疗领域的专业经验，以及威斯康星大学麦迪逊分校在免疫学与临床研究方面的学术优势。Agent-797作为一种创新疗法，有望为接受异体造血干细胞移植的患者提供新的免疫调控策略。\n研究团队将密切关注试验进展，期待为移植物抗宿主病的预防开辟新的治疗路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"1106320187","title":"Mink Therapeutics公布2025年第三季度财报并加速Inkt平台在肿瘤学、肺病和移植领域的关键开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1106320187","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106320187?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:31","pubTimestamp":1763123471,"startTime":"0","endTime":"0","summary":"Mink Therapeutics公布2025年第三季度财报并加速Inkt平台在肿瘤学、肺病和移植领域的关键开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"1113557791","title":"MiNK Therapeutics在SITC 2025上报告了Allo-Inkt细胞疗法Agent-797在PD-1耐药实体肿瘤中的持久反应和免疫重激活","url":"https://stock-news.laohu8.com/highlight/detail?id=1113557791","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113557791?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:06","pubTimestamp":1762524393,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics在SITC 2025上报告了Allo-Inkt细胞疗法Agent-797在PD-1耐药实体肿瘤中的持久反应和免疫重激活。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"1125774714","title":"MiNK Therapeutics 2025财年Q2业绩会总结及问答精华：INKT疗法的临床突破与战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1125774714","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125774714?lang=zh_cn&edition=full","pubTime":"2025-08-14 23:53","pubTimestamp":1755186787,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics继续在工业化现成的iNKT细胞方面处于领先地位，强调其在免疫重建和疾病消除中的重要性。公司计划在2025年底前发布胃癌二期试验的顶线数据，启动GVHD一期试验，并推进MINC215项目。战略合作的可能性被强调，预计将进一步推动项目执行。INKT细胞在预临床模型中显示出更高的耐受性和有效性。MiNK Therapeutics在2025财年第二季度展示了其INKT疗法在临床上的突破性进展，尤其是在癌症和免疫介导疾病中的应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"gpt_icon":0},{"id":"2558505537","title":"Mink Therapeutics, Inc.8月8日成交额为212.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558505537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558505537?lang=zh_cn&edition=full","pubTime":"2025-08-09 11:11","pubTimestamp":1754709067,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Mink Therapeutics, Inc.成交额为212.36万美元，成交额较昨日增加33.20%，当日成交量为17.62万股。Mink Therapeutics, Inc.于2025年8月8日跌4.74%，报12.06美元，该股过去5个交易日跌18.07%，年初至今涨73.03%，过去60日涨65.43%。该公司正在推进一系列原生和下一代工程iNKT项目，其平台旨在促进可扩展和可重复的制造，以实现现成的交付。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809111114a6dbfdc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809111114a6dbfdc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INKT","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2518308222","title":"Mink Therapeutics, Inc.盘中异动 早盘急速跳水8.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518308222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518308222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:44","pubTimestamp":1741614241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时44分，Mink Therapeutics, Inc.股票出现异动，股价快速跳水8.05%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2390.07%、561.77%、84.34%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214401abf30117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214401abf30117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2517947192","title":"Mink Therapeutics, Inc.盘中异动 股价大涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517947192?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:42","pubTimestamp":1741196552,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时42分，Mink Therapeutics, Inc.股票出现异动，股价大幅拉升6.30%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014232963b06ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014232963b06ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2516677322","title":"Mink Therapeutics, Inc.盘中异动 快速下挫9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677322?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:30","pubTimestamp":1741098649,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时30分，Mink Therapeutics, Inc.股票出现波动，股价急速跳水9.47%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223050989bab88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223050989bab88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2513629652","title":"Mink Therapeutics, Inc.盘中异动 早盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513629652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513629652?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:34","pubTimestamp":1740148490,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时34分，Mink Therapeutics, Inc.股票出现波动，股价急速上涨5.30%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223450abd7b04e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223450abd7b04e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2510380389","title":"Mink Therapeutics, Inc.盘中异动 早盘大幅上涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380389?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Mink Therapeutics, Inc.股票出现异动，股价快速拉升6.43%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223227961f47be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223227961f47be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2509277498","title":"Mink Therapeutics, Inc.盘中异动 快速拉升5.67%报11.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277498?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:44","pubTimestamp":1738853044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时44分，Mink Therapeutics, Inc.股票出现异动，股价快速拉升5.67%。截至发稿，该股报11.47美元/股，成交量9870股，换手率0.25%，振幅8.02%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224404a23bd15a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224404a23bd15a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2508457999","title":"Mink Therapeutics, Inc.盘中异动 早盘大幅下跌6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457999?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:38","pubTimestamp":1738679939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时38分，Mink Therapeutics, Inc.股票出现异动，股价快速跳水6.87%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223859987a4b93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223859987a4b93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INKT"],"gpt_icon":0},{"id":"2508149126","title":"Mink Therapeutics, Inc.盘中异动 早盘快速跳水5.24%报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149126?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Mink Therapeutics, Inc.股票出现异动，股价快速跳水5.24%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223209abc106da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223209abc106da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2507621300","title":"Mink Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报7.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621300?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:38","pubTimestamp":1738247912,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时38分，Mink Therapeutics, Inc.股票出现异动，股价急速上涨6.06%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223832abbd4dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223832abbd4dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2506067583","title":"Mink Therapeutics, Inc.盘中异动 急速跳水6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506067583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506067583?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:12","pubTimestamp":1737990775,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时12分，Mink Therapeutics, Inc.股票出现异动，股价快速跳水6.91%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231255abba6883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231255abba6883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2505662268","title":"Mink Therapeutics, Inc.盘中异动 急速下挫9.39%报0.884美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505662268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505662268?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:35","pubTimestamp":1737729342,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时35分，Mink Therapeutics, Inc.股票出现波动，股价急速下挫9.39%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223542a22e5afb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223542a22e5afb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INKT","BK4139"],"gpt_icon":0},{"id":"2505043945","title":"Mink Therapeutics, Inc.盘中异动 大幅跳水5.66%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505043945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505043945?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:09","pubTimestamp":1737648542,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时09分，Mink Therapeutics, Inc.股票出现波动，股价急速下跌5.66%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124000902960e5794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124000902960e5794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0},{"id":"2505096602","title":"Mink Therapeutics, Inc.盘中异动 大幅拉升7.95%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505096602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505096602?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:00","pubTimestamp":1737478821,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时00分，Mink Therapeutics, Inc.股票出现波动，股价大幅拉升7.95%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.82%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010021986e4d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010021986e4d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INKT"],"gpt_icon":0},{"id":"2504616091","title":"Mink Therapeutics, Inc.盘中异动 早盘快速拉升5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504616091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504616091?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:31","pubTimestamp":1737124318,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时31分，Mink Therapeutics, Inc.股票出现波动，股价大幅拉升5.58%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，专注开发同种异体不变的自然杀伤T细胞疗法，以治疗癌症和其他危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223158abaeb096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223158abaeb096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INKT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0369},{"period":"1month","weight":-0.1268},{"period":"3month","weight":0.0419},{"period":"6month","weight":-0.231},{"period":"1year","weight":0.2033},{"period":"ytd","weight":-0.0179}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiNK Therapeutics, Inc.于2017年7月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，率先发现、开发和商业化同种异体、现成的iNKT细胞疗法，以治疗癌症和其他免疫介导的疾病。该公司正在利用其平台和制造能力开发一条全资或独家许可的天然和工程iNKT细胞管道，并预计在2021年和2022年进行多项临床和临床前读数。公司的战略是推进可访问、可扩展且有效的细胞治疗平台，利用iNKT细胞的先天和持久的生物学优势，优化可扩展性和快速临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.041395},{"month":2,"riseRate":0.2,"avgChangeRate":-0.047548},{"month":3,"riseRate":0,"avgChangeRate":-0.089419},{"month":4,"riseRate":0.25,"avgChangeRate":-0.026851},{"month":5,"riseRate":0,"avgChangeRate":-0.100407},{"month":6,"riseRate":0.5,"avgChangeRate":0.033071},{"month":7,"riseRate":0.25,"avgChangeRate":0.215487},{"month":8,"riseRate":0.25,"avgChangeRate":0.146012},{"month":9,"riseRate":0,"avgChangeRate":-0.132506},{"month":10,"riseRate":0.5,"avgChangeRate":-0.021174},{"month":11,"riseRate":0.6,"avgChangeRate":-0.066406},{"month":12,"riseRate":0.4,"avgChangeRate":-0.119867}],"exchange":"NASDAQ","name":"MiNK Therapeutics, Inc.","nameEN":"MiNK Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiNK Therapeutics, Inc.,INKT,MiNK Therapeutics, Inc.股票,MiNK Therapeutics, Inc.股票老虎,MiNK Therapeutics, Inc.股票老虎国际,MiNK Therapeutics, Inc.行情,MiNK Therapeutics, Inc.股票行情,MiNK Therapeutics, Inc.股价,MiNK Therapeutics, Inc.股市,MiNK Therapeutics, Inc.股票价格,MiNK Therapeutics, Inc.股票交易,MiNK Therapeutics, Inc.股票购买,MiNK Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiNK Therapeutics, Inc.(INKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiNK Therapeutics, Inc.(INKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}